In Brief: Plaque meeting
This article was originally published in The Tan Sheet
Plaque meeting: FDA's Dental Products Panel's Plaque Subcommittee is scheduled to meet Aug. 14 beginning at 9 a.m. in Conference Room G of FDA's Parklawn Building in Rockville, Md., according to the July 21 Federal Register. The subcommittee is expected to continue a discussion begun in December 1994 on guidelines for the safety and efficacy of antiplaque products ("The Tan Sheet" April 17, pp. 8-15), and will focus on the ingredients cetylpyridinium chloride, and amylase, protease and lipase...
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC